Login to Your Account

Sanofi-Genzyme: BioMarin to Win, NPS Next Tempter?

By Randy Osborne

Monday, August 9, 2010

"Change of control." It's one of those legal phrases in a contract that, when brought into play, can strike terror or joy into the heart of one side of a partnership or another who might have more casually agreed years earlier. The concept could take center stage for BioMarin Pharmaceutical Inc. in the firm's deal with Genzyme Corp. if Sanofi-Aventis SA goes ahead with a persistent bid to take over Cambridge, Mass.-based Genzyme Corp. – a bid that speculators predicted could turn hostile.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription